Companion Diagnostics Play a Confusing Role with PD-1 Inhibitors

  There are now three approved drugs that target PD-1 either directly or indirectly, and more are under development.While these drugs all seek to inhibit PD-1’s immune suppressive activity, they are quite different in the ways that companion diagnostic tests play...

Cancer Drugs: A Long Road to Blockbuster Sales

This article was originally published on WSJ.com by Charley Grant on May 30, 2016. Novel cancer treatments are the next big hope for the drug sector. But investors shouldn’t forget that reward goes hand in hand with risk. Download the full report: Clincial Development...

Cancer Drugs Are The Least Likely to Receive FDA Approval

This article was originally published on Fortune.com, by Sy Mukherjee May 26, 2016. But there’s good reason to hope that may change very soon. This post was corrected/updated on Monday, May 30. A massive new study of drug candidates sheds light on which experimental...

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access